Calf Augmentation in Escondido California
This procedure offers a solution for those people that have underdeveloped calves or wish to augment them. The idea is to shape and size the calves by surgical insertion of implants. The implants are made of soft silicon and they come in different shapes and sizes. Before the operation your legs will be measured to select a proper implant for your needs. There is an alternative to implants. Calf augmentation can also be performed by liposuction of fat from other body parts and injecting it into the calves. This method is not suitable for people with no extra fat to be removed. Another problem is fat absorption that eventually occurs, sometimes creating not symmetric calves. Men and women can benefit from this procedure. Men usually want to increase the muscle bulk, giving them more masculine look and women wish to get more symmetrical appearance of their legs. This procedure also may help to correct some congenital defects, those include polio, spina bifida and clubfoot, all this conditions may be associated with undeveloped calves.
This procedure can be done with local or general anesthesia, and it usually lasts for an hour. During the operation the patient is laying on their back. A cut is made in the concavity behind the knee, then the skin is gently separated and a space is created. The implant is inserted above the muscles. After one leg is done the doctor performs the same on the other one. After the symmetry is confirmed the surgeon closes the cuts with stitches.
Every operation has its ricks. This one includes bleeding, infection and sometimes implants shrinkage and asymmetry.
After the surgery you may feel some degree of pain. Your doctor'll subscribe you for painkillers. At the first two days you'll be asked to raise your legs whenever you are sitting, this to reduce swelling. Afterwards, the bandages are removed and you are encouraged to walk more intensively to train your calve muscles. For about two weeks you'll fell like you're calves is been through excessive workout. Swelling and bruising also may appear, they are only temporary and will improve with time. You'll be able to go back to work after 7-10 days. You'll get detailed instructions from you're surgeon regarding the activities you should avoid, for example long walking, weight lifting and running. Usually, most of the patients are able to return to their daily activities after 4-6 weeks.
More Escondido info...
Escondido Eat Hernandez' Hideaway Restaurant 19320 Lake Dr, (760) 746-1444
Agrusa's Sandwich Shop 1606 E Valley Pkwy, (760) 746-0666
Fat Ivor's Rib Rack 27961 Valley Center Rd Valley Center, CA 92082 (760) 749-0600 Burned down in 2003, but is now reopened; pit barbecue smoked pork and beef ribs to drool for.
Escondido Get out This article is an outline and needs more content. It has a template, but there is not enough information present. Please plunge forward and help it grow!
Plastic Surgery News...
- Doctors do not think like the general public when it comes to making decisions about how to treat - or not treat - severely ill patients. According to research published in the open access journal Critical Care, the majority of doctors would withhold treatment in certain circumstances, whereas most members of the public would not.
- Though treatment of secondary hyperparathyroidism with activated vitamin D analogues is linked to better survival in patients on dialysis., it is unknown if this is the case for patients with chronic kidney disease (CKD) not on dialysis. Therefore, researchers examined the link between oral calcitriol treatment, mortality and the incidence of dialysis in 520 male US veterans (mean age, 69.8 years; 23.5% black) with CKD stages 3 to 5, not yet receiving dialysis (mean estimated GFR 30.8 ml/min). Adjustments were made for age, race, comorbidities, smoking, BP, BMI, use of phosphate binders, estimated GFR, proteinuria, white blood cell count, percentage of lymphocytes, and levels of PTH, calcium, phosphorus, albumin, bicarbonate, and haemoglobin.
In the study, 258 patients received calcitriol, 0.25 to 0.5mcg/d, for a median duration of 2.1 years. The incidence rate ratios for mortality and combined death and dialysis initiation were statistically significantly lower in treated vs. untreated patients (0.35; 95% CI, 0.23 to 0.54; p < 0.001 and 0.46; 0.35 to 0.61, respectively) in the fully adjusted models. These results were consistent across different subgroups.
The researchers conclude that treatment of secondary hyperparathyroidism with calcitriol in patients with CKD stages 3 to 5 not yet on dialysis appears to be linked to statistically significantly greater survival. However, they acknowledge that RCTs are required to verify these observations and examine whether similar associations are seen with different activated vitamin D analogues.